COVID-19 Vaccination Syringes Prepared & Distributed by RAMM Pharma
TORONTO RAMM Pharma Corp., a cannabinoid pharmaceutical products company, announces that the Uruguayan Ministry of Public Health, (Ministerio de Salúd Publica or “MSP”) has selected RAMM as a fulfilment and distribution partner for Uruguay’s COVID-19 vaccination program. Under the arrangement, RAMM will be responsible for the sterilization, packaging and distribution of syringes and other medical supplies for use in the country’s COVID-19 vaccination program. RAMM’s GMP certified pharmaceutical facility was selected for the program upon satisfaction of the requirements of the Ministry of Public Health.
“We are pleased to play an integral role in Uruguay’s COVID-19 vaccination effort. Our selection by the Ministry of Public Health is a testament to our longstanding relationship and recognition of the specialized capabilities of our team and GMP facility within the pharmaceutical community,” stated
RAMM Pharma Selected as COVID-19 Vaccine Fulfilment & Distribution Partner by the Uruguayan Ministry of Health
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
2021 Recruiting Breakdown: Air Force
mwcconnection.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mwcconnection.com Daily Mail and Mail on Sunday newspapers.
Canapar Welcomes RAMM Pharma as Strategic Shareholder; Closes $6,427,000 Financing
January 20, 2021 09:48 ET | Source: Canapar Corp. Canapar Corp. Toronto, Ontario, CANADA
RAGUSA, Italy, Jan. 20, 2021 (GLOBE NEWSWIRE) Canapar Corp. (“Canapar”) and RAMM Pharma Corp. (including its wholly owned subsidiaries, RAMM ) (CSE: RAMM) are pleased to announce they have entered into a strategic partnership, combining Canapar’s hemp-derived cannabidiol (CBD) extraction expertise with RAMM’s leadership in cannabis-derived pharmaceutical and cosmeceutical products. As part of the strategic partnership, RAMM has acquired Canopy Rivers’ (TSX: RIV) (OTC: CNPOF) 49% ownership interest in Canapar. This investment is expected to immediately enhance both RAMM and Canapar’s ability to capitalize on the rapidly expanding European and South American hemp-derived CBD markets.